Anja Geerts

7.9k total citations · 2 hit papers
175 papers, 3.6k citations indexed

About

Anja Geerts is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Anja Geerts has authored 175 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Epidemiology, 81 papers in Hepatology and 57 papers in Surgery. Recurrent topics in Anja Geerts's work include Liver Disease Diagnosis and Treatment (93 papers), Liver Disease and Transplantation (53 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Anja Geerts is often cited by papers focused on Liver Disease Diagnosis and Treatment (93 papers), Liver Disease and Transplantation (53 papers) and Organ Transplantation Techniques and Outcomes (27 papers). Anja Geerts collaborates with scholars based in Belgium, Germany and United States. Anja Geerts's co-authors include Hans Van Vlierberghe, Isabelle Colle, Xavier Verhelst, Christophe Van Steenkiste, Lindsey Devisscher, Sander Lefere, Femke Heindryckx, Sarah Raevens, Stéphanie Coulon and Roberto Troisi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Anja Geerts

168 papers receiving 3.5k citations

Hit Papers

Differential effects of selective- and pan-PPAR agonists ... 2020 2026 2022 2024 2020 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Geerts Belgium 34 1.9k 1.6k 922 762 394 175 3.6k
Hideki Fujii Japan 33 2.5k 1.3× 1.5k 1.0× 814 0.9× 631 0.8× 281 0.7× 156 3.9k
Alessia Omenetti United States 35 1.8k 0.9× 1.8k 1.1× 1.1k 1.2× 1.9k 2.6× 371 0.9× 58 4.3k
Hiroyuki Kirikoshi Japan 36 2.1k 1.1× 936 0.6× 993 1.1× 1.2k 1.5× 294 0.7× 138 4.0k
Yuzo Kodama Japan 28 1.7k 0.9× 903 0.6× 1.4k 1.5× 1.1k 1.4× 343 0.9× 195 4.5k
Hirohide Ohnishi Japan 31 1.4k 0.7× 595 0.4× 1.2k 1.3× 1.2k 1.6× 529 1.3× 100 3.7k
Honglei Weng Germany 32 1.1k 0.6× 1.2k 0.7× 479 0.5× 1.2k 1.5× 215 0.5× 79 3.2k
Thomas G. Bird United Kingdom 24 910 0.5× 1.3k 0.8× 1.0k 1.1× 1.2k 1.6× 202 0.5× 77 3.7k
Casey D. Johnson United States 21 2.0k 1.0× 907 0.6× 434 0.5× 2.0k 2.7× 349 0.9× 35 3.8k
Yoshihiro Ikura Japan 31 958 0.5× 537 0.3× 659 0.7× 577 0.8× 223 0.6× 103 3.1k
Siegfried Matern Germany 34 1.2k 0.6× 1.1k 0.7× 1.1k 1.2× 617 0.8× 185 0.5× 79 3.8k

Countries citing papers authored by Anja Geerts

Since Specialization
Citations

This map shows the geographic impact of Anja Geerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Geerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Geerts more than expected).

Fields of papers citing papers by Anja Geerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Geerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Geerts. The network helps show where Anja Geerts may publish in the future.

Co-authorship network of co-authors of Anja Geerts

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Geerts. A scholar is included among the top collaborators of Anja Geerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Geerts. Anja Geerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casteleyn, Christophe, Sara Neyt, Benedicte Descamps, et al.. (2025). The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature. Biomedicine & Pharmacotherapy. 183. 117826–117826. 2 indexed citations
2.
Pauw, Michel De, Xavier Verhelst, Sander Lefere, et al.. (2025). Diastolic dysfunction: Prevalence and outcome in liver transplantation candidates. Annals of Hepatology. 30(2). 101784–101784.
3.
Gansemans, Yannick, Joél Smet, Xavier Verhelst, et al.. (2025). Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD. JHEP Reports. 7(6). 101404–101404. 1 indexed citations
4.
Paepe, Ellen De, Stefaan De Henauw, Nathalie Michels, et al.. (2025). A repository of the salivary metabolome and its key drivers in 1436 European children. EBioMedicine. 122. 106019–106019.
5.
Paepe, Kim De, Hans Van Vlierberghe, Sarah Raevens, et al.. (2025). The double-edged sword of metabolic and bariatric surgery: extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation – an experimental study. International Journal of Surgery. 111(7). 4239–4251. 2 indexed citations
6.
Lefere, Sander, et al.. (2024). Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease. SHILAP Revista de lepidopterología. 2(1). 13–13. 7 indexed citations
7.
Geerts, Anja, et al.. (2024). Role of astrocytes and microglia in hepatic encephalopathy associated with advanced chronic liver disease: lessons from animal studies. Neural Regeneration Research. 20(12). 3461–3475. 3 indexed citations
8.
Hoecke, Lien Van, Griet Van Imschoot, Elien Van Wonterghem, et al.. (2023). Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes. Journal of Neuroinflammation. 20(1). 130–130. 9 indexed citations
9.
Vanderborght, Bart, Kevin De Muynck, Eva Gijbels, et al.. (2023). Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte‐derived cells does not alter the induction or progression of hepatocellular carcinoma. International Journal of Cancer. 152(12). 2615–2628. 6 indexed citations
11.
Hoorens, Anne, et al.. (2023). Treatment of Refractory Checkpoint-Inhibitor-Induced Hepatitis with Tacrolimus: A Case and Review of the Literature. SHILAP Revista de lepidopterología. 3(3). 274–285. 1 indexed citations
12.
Muynck, Kevin De, Bart Vanderborght, Federico F. De Ponti, et al.. (2023). Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis. American Journal Of Pathology. 193(4). 366–379. 9 indexed citations
13.
Dhondt, Elisabeth, Bieke Lambert, Laurens Hermie, et al.. (2022). 90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial. Radiology. 303(3). 699–710. 100 indexed citations breakdown →
14.
Hoecke, Lien Van, Sander Lefere, Anja Geerts, et al.. (2021). The neurogliovascular unit in hepatic encephalopathy. JHEP Reports. 3(5). 100352–100352. 37 indexed citations
15.
Geerts, Anja, et al.. (2018). Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening. Pediatric Cardiology. 39(8). 1604–1613. 15 indexed citations
16.
Verhelst, Xavier, Dieter Vanderschaeghe, Laurent Castéra, et al.. (2016). A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis. Clinical Cancer Research. 23(11). 2750–2758. 28 indexed citations
17.
Verhelst, Xavier, Anja Geerts, & Hans Van Vlierberghe. (2016). Cirrhosis: Reviewing the Literature and Future Perspectives. 111–117. 2 indexed citations
18.
Moreno, Christophe, Luc Lasser, Jean Delwaide, et al.. (2015). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium. Hepatology. 62(1). 746. 3 indexed citations
19.
Steenkiste, Christophe Van, Anja Geerts, Hans Van Vlierberghe, et al.. (2010). LTx for alcoholic liver disease: a retrospective analysis of recidivism, survival and risk factors predisposing to alcohol relapse. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
20.
Hautekèete, M., et al.. (1997). Limited evidence for redistribution of vitamin A from liver to oesophageal mucosa in chronic liver disease in humans. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026